首页> 美国卫生研究院文献>Molecular Therapy. Methods Clinical Development >Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions
【2h】

Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions

机译:在定义的体外反应中高效生产乳头瘤病毒基因递送载体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Papillomavirus capsids can package a wide variety of nonviral DNA plasmids and deliver the packaged genetic material to cells, making them attractive candidates for targeted gene delivery vehicles. However, the papillomavirus vectors generated by current methods are unlikely to be suitable for clinical applications. We have developed a chemically defined, cell-free, papillomavirus-based vector production system that allows the incorporation of purified plasmid DNA (pseudogenome) into high-titer papillomavirus L1/L2 capsids. We investigated the incorporation of several DNA forms into a variety of different papillomavirus types, including human and animal types. Our results show that papillomavirus capsids can package and transduce linear or circular DNA under defined conditions. Packaging and transduction efficiencies were surprisingly variable across capsid types, DNA forms, and assembly reaction conditions. The pseudoviruses produced by these methods are sensitive to the same entry inhibitors as cell-derived pseudovirions, including neutralizing antibodies and heparin. The papillomavirus vector production systems developed in this study generated as high as 1011 infectious units/mg of L1. The pseudoviruses were infectious both in vitro and in vivo and should be compatible with good manufacturing practice (GMP) requirements.
机译:乳头瘤病毒衣壳可以包装多种非病毒DNA质粒,并将包装的遗传物质递送至细胞,使其成为靶向基因递送载体的诱人候选物。然而,通过当前方法产生的乳头瘤病毒载体不太可能适合临床应用。我们已经开发出一种化学上定义的,无细胞的,基于乳头瘤病毒的载体生产系统,该系统可将纯化的质粒DNA(假基因组)掺入高滴度乳头瘤病毒L1 / L2衣壳中。我们调查了几种DNA形式掺入各种不同的乳头瘤病毒类型,包括人和动物类型。我们的结果表明,乳头瘤病毒衣壳可以在规定条件下包装和转导线性或环状DNA。包装和转导效率因衣壳类型,DNA形式和组装反应条件而异。通过这些方法产生的假病毒对与细胞衍生的假病毒颗粒相同的进入抑制剂敏感,包括中和抗体和肝素。在这项研究中开发的乳头瘤病毒载体生产系统可产生高达10 11 感染单位/毫克的L1。伪病毒在体外和体内均具有感染性,应符合良好生产规范(GMP)要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号